Read More 2 minute read Penny Stocks UCASU: Diversification into agriculture properties continues By Zacks Small Cap Research Today, 7:51 AM By Beth Senko, CFA OTC:UCASU READ THE FULL UCASU RESEARCH REPORT PURA
Read More 5 minute read Uncategorized SQZ: IND Cleared for Enhanced APCs By Zacks Small Cap Research Today, 7:51 AM By John Vandermosten, CFA NYSE:SQZ READ THE FULL SQZ RESEARCH REPORT SQZ
Read More 6 minute read Uncategorized SBEV: Beverage Player With Expanding Brand Portfolio, Strong Distribution Network & Growth Strategy By Zacks Small Cap Research Today, 7:51 AM By M. Marin NYSE:SBEV PRODUCT PORTFOLIO SBEV
Read More 4 minute read Small Cap EPIX: First Patient Dosed in Combination Trial of EPI-7386 and Enzalutamide… By Zacks Small Cap Research Today, 7:51 AM By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT EPIX
Read More 6 minute read Penny Stocks LEXX: 1Q:22 Results & Other Things that Came Up By Zacks Small Cap Research Today, 7:51 AM By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT LEXX
Read More 4 minute read Penny Stocks VIVXF: More Favorable Business Conditions Likely in 2022… By Zacks Small Cap Research Today, 7:51 AM By David Bautz, PhD OTC:VIVXF READ THE FULL VIVXF RESEARCH REPORT VIVXF
Read More 3 minute read Penny Stocks BICX: Pandemic surge leads to worsening trend in opioid deaths By Zacks Small Cap Research Today, 7:51 AM By Beth Senko, CFA OTC:BICX READ THE FULL BICX RESEARCH REPORT BICX
Read More 5 minute read Penny Stocks BIOAF: Third Quarter Results By Zacks Small Cap Research Today, 7:51 AM By John Vandermosten, CFA OTC:BIOAF READ THE FULL BIOAF RESEARCH REPORT BIOAF
Read More 4 minute read Penny Stocks BLRX: Initiating on BioLineRx: Mobilizing the Troops with Motixafortide By Zacks Small Cap Research Today, 7:51 AM By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT BLRX
Read More 3 minute read Penny Stocks OIIM: Q4 Revenues Were Hurt By Now-Resolved Production Issues for Wafers By Zacks Small Cap Research Today, 7:51 AM By Lisa Thompson NASDAQ:OIIM READ THE FULL OIIM RESEARCH REPORT OIIM